Elicio Therapeutics Inc. (ELTX) Stock Analysis

Elicio Therapeutics Inc. (ELTX) is a publicly traded company in the HEALTHCARE sector. It trades at $11.49, carries a market capitalization of $218.34M. This page summarizes the public market data, fundamentals, and frequently asked questions for ELTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $11.49
• Market Cap: $218.34M
• EPS: $-2.36
• 52-Week High: $14.93
• 52-Week Low: $7.37

Market Sentiment

Elicio Therapeutics Inc. currently has a Bullish sentiment score of 0.47.

About Elicio Therapeutics Inc.

None

GNG Research Analysis

GNG Research scores Elicio Therapeutics Inc. (ELTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ELTX.

Frequently Asked Questions

Does ELTX pay dividends?

Elicio Therapeutics Inc. (ELTX) does not currently pay a regular dividend.

What is ELTX's market cap?

Elicio Therapeutics Inc. (ELTX) has a market capitalization of $218.34M with a current stock price of $11.49.